NeuroPathways Intervention for Brain Tumor Patients
Sponsor: Massachusetts General Hospital • ClinicalTrials.gov ID: NCT05976490
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.
Interventions
-
Information and Support Intervention
(Behavioral)
Information guide and four one-on-one coaching sessions
-
Usual supportive care
(Other)
Referral to cancer center supportive care services (e.g., social work) upon request from the patient, caregiver, or clinician
Eligibility criteria
Conditions
Locations
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record